- Home
- SNY vs ADI Comparison
SNY vs ADI Comparison
Compare SNY & ADI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- ADI
- Stock Information
- Founded
- SNY 1994
- ADI 1965
- Country
- SNY France
- ADI United States
- Employees
- SNY N/A
- ADI N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- ADI Semiconductors
- Sector
- SNY Health Care
- ADI Technology
- Exchange
- SNY Nasdaq
- ADI Nasdaq
- Market Cap
- SNY 140.6B
- ADI 113.3B
- IPO Year
- SNY N/A
- ADI 1972
- Fundamental
- Price
- SNY $57.73
- ADI $213.64
- Analyst Decision
- SNY Buy
- ADI Buy
- Analyst Count
- SNY 2
- ADI 21
- Target Price
- SNY $57.50
- ADI $249.42
- AVG Volume (30 Days)
- SNY 1.6M
- ADI 3.3M
- Earning Date
- SNY 10-25-2024
- ADI 08-21-2024
- Dividend Yield
- SNY 3.53%
- ADI 1.72%
- EPS Growth
- SNY N/A
- ADI N/A
- EPS
- SNY 3.60
- ADI 3.31
- Revenue
- SNY $50,444,658,733.00
- ADI $9,700,436,000.00
- Revenue This Year
- SNY $3.58
- ADI N/A
- Revenue Next Year
- SNY $6.99
- ADI $10.35
- P/E Ratio
- SNY $32.20
- ADI $64.52
- Revenue Growth
- SNY 2.25
- ADI N/A
- 52 Week Low
- SNY $42.63
- ADI $154.99
- 52 Week High
- SNY $58.97
- ADI $244.14
- Technical
- Relative Strength Index (RSI)
- SNY 71.75
- ADI 42.98
- Support Level
- SNY $55.80
- ADI $217.65
- Resistance Level
- SNY $58.97
- ADI $236.14
- Average True Range (ATR)
- SNY 0.58
- ADI 6.58
- MACD
- SNY 0.16
- ADI -0.82
- Stochastic Oscillator
- SNY 74.38
- ADI 3.89
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About ADI Analog Devices Inc.
Analog Devices is a leading analog, mixed signal, and digital signal processing chipmaker. The firm has a significant market share lead in converter chips, which are used to translate analog signals to digital and vice versa. The company serves tens of thousands of customers, and more than half of its chip sales are made to industrial and automotive end markets. Analog Devices' chips are also incorporated into wireless infrastructure equipment.